YFYingmei Fu

Yingmei Fu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yingmei Fu has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Fengmin Zhang

    Heilongjiang Provincial Key Laboratory of Infection and Immunity, Department of Microbiology, School of Basic Medical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150081, China

    7 shared publications
  • Xinyang Wang

    Department of Microbiology, Harbin Medical University , Harbin , China

    4 shared publications
  • Fengmin Zhang

    Department of Microbiology, School of Basic Medical Sciences, WU Lien-Teh Institute, Harbin Medical University, Harbin, China

    3 shared publications
  • Qingtai Meng

    Department of Microbiology, Harbin Medical University , Harbin , China

    3 shared publications
  • Wadee Abdullah Al-Shehari

    Medical Microbiology Department, Faculty of Medical Sciences, Ibb University, Ibb, Yemen

    3 shared publications
  • Wei Gu

    Department of Microbiology, School of Basic Medical Sciences, WU Lien-Teh Institute, Harbin Medical University, Harbin, China

    3 shared publications

Latest Publications

  • Open Access

    Epidemiology of cutaneous leishmaniasis in Ibb governorate, Yemen: trends and public health challenges amidst the COVID-19 pandemic

    by Wadee Abdullah Al-Shehari, Yingmei Fu, Fengmin Zhang, Xiaoli Zhang, Wadhah Hassan Edrees, Ali Ahmed Al-Hadheq, Eglal Ahmed Qasem, Reem Alariqi, Ahmed Mohammed Al-Haddad

    Cutaneous Leishmaniasis (CL) is one of the neglected tropical diseases that causes a significant public health problem for the public in many endemic natio


  • Open Access

    Peripheral blood microbiome signature and Mycobacterium tuberculosis-derived rsRNA as diagnostic biomarkers for tuberculosis in human

    by Wei Gu, Zhigang Huang, Yunfan Fan, Ting Li, Xinyuan Yu, Zhiyuan Chen, Yan Hu, Aimei Li, Fengmin Zhang, Yingmei Fu

    Tuberculosis (TB) is a major global health issue. Early diagnosis of TB is still a challenge. Studies are seeking non-sputum biomarker-based TB test. Emerging evidence indicates potential significance of blood microbiome signatures for diseases. However, blood microbiome RNA profiles are unknown in TB. We aimed to characterize the blood microbiome of TB patients and identify Mycobacterium tuberculosis (Mtb) genome-derived small RNA molecules to serve as diagnostic biomarkers for TB. RNA sequencing data of the blood from TB patients and healthy controls were retrieved from the NCBI-SRA database for analyzing the blood microbiome and identifying rRNA-derived small RNA (rsRNA) of Mtb. Small RNA-seq was performed on plasma exosomes from TB patients and healthy controls. The levels of the candidate Mtb rsRNAs were determined by real-time quantitative reverse transcription PCR (RT-qPCR) on plasma from a separate cohort of 73 TB patients and 62 healthy controls. The blood microbiome of TB patients consisted of RNA signals from bacteria, fungi, archaea, and viruses, with bacteria accounting for more than 97% of the total. Reduced blood microbial diversity and abundance of 6 Mycobacterium-associated bacterial genera, including Mycobacterium, Priestia, Nocardioides, Agrobacterium, Bradyrhizobium, and Escherichia, were significantly altered in the blood of TB patients. A diagnostic model for TB based on the 6 genera achieved an area under the curve (AUC) of 0.8945. rsRNAs mapped to the Mtb genome were identified from blood and plasma exosomes of TB patients. RT-qPCR results showed that 2 Mtb-derived rsRNAs, 16 S-L1 and 16 S-L2, could be used as diagnostic biomarkers to differentiate TB patients from healthy controls, with a high co-diagnostic efficacy (AUC = 0.7197). A panel of blood microbiome signatures and Mtb-derived rsRNAs can serve as blood biomarkers for TB diagnosis.


  • Circular RNAs in tuberculosis and lung cancer

    by Sadia Jabeen, Niaz Ahmed, Faiqa Rashid, Nand Lal, Fanhui Kong, Yingmei Fu, Fengmin Zhang


  • Open Access

    Identification of RNU44 as an Endogenous Reference Gene for Normalizing Cell-Free RNA in Tuberculosis

    by Wei Gu, Xilin Tu, Weinan Lu, Yian Yin, Qingtai Meng, Xinyang Wang, Fengmin Zhang, Yingmei Fu

    Normalization of cell-free RNA (cf-RNA) concentration can be affected by variable experimental conditions and thus impact the performance of their diagnostic potential. Our study aimed to identify appropriate endogenous reference genes for cf-RNA biomarker evaluation in the diagnosis of tuberculosis (TB). Subjects consisting of patients with TB with and without malignancy, patients with pneumonia, and healthy controls were recruited. Candidate reference genes were screened and identified by literature reviewing and RNA-Seq analysis. Expression levels of the candidate genes were determined by reverse-transcription real-time quantitative polymerase chain reaction in plasma from patients with TB and healthy controls. The stability of gene expression was assessed by geNorm, NormFinder, BestKeeper, the Comparative Delta Ct method, and RefFinder. Differential expression of 2 small RNAs (sRNAs) encoding by genome of Mycobacterium tuberculosis in plasma of patients with TB were determined by both absolute quantification and relative quantification with candidate reference genes. According to the stability ranking analyzed with the 5 computational programs, the top 4 candidates—miR-93, RNU44, miR-16, and glyceraldehyde 3-phosphate dehydrogenase—were used to normalize the transcript levels of 2 mycobacterial sRNAs, MTS2823 and MTS1338, which were observed to have higher copy numbers in the plasma of patients with TB. Normalization with RNU44 displayed significantly higher levels of the 2 M tuberculosis sRNAs in the patients’ plasma than those of healthy controls. RNU44 was demonstrated as a proper endogenous gene for cf-RNA normalization in TB diagnosis.


  • Open Access

    Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018 – ERRATUM

    by Wadee Abdullah Al-Shehari, Yi-An Yin, Xinyang Wang, Ying Wang, Haobo Sun, Yingmei Fu, Fengmin Zhang


  • Open Access

    Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018

    by Wadee Abdullah Al-Shehari, Yi-An Yin, Xinyang Wang, Ying Wang, Haobo Sun, Yingmei Fu, Fengmin Zhang

    Tuberculosis is a major public health issue in Yemen, a country located at the southwestern tip of the Arabian Peninsula, while the situation of tuberculosis had been further exacerbated since the war started in 2015. The objective of this study is to investigate the incidence of tuberculosis in Yemen before the outbreak of COVID-19, from 2006 to 2018. During the 13-year period, 92 482 patients were enrolled in the TB programme records from the 22 governorates. Almost equal number of cases were diagnosed between males and females (a male to female ratio, 1.03:1). A notable rising incidence was observed in all age groups starting from 2011. The sharpest increase occurred in children under age 15, rising by 8.0-fold from 0.5 in the period 2006–2010 to 4.1 in the period 2011–2018. Paediatric TB accounted for 9.6% of all reported cases. In terms of the patient residence, incidence has more than doubled in Sana'a city, Sana'a Gov., Hajjah and Saadah. Concomitant diseases with tuberculosis included diabetes mellitus (14.0%), brucellosis (6.1%), hepatitis (6.0%), rheumatoid arthritis (4.3%), renal disorders (2.5%) and HIV infection (2.5%). Development of interventions to reduce tuberculosis incidence in children and concomitant communicable diseases is urgently needed.


  • Genome-Wide Screening and Characterization of Genes Involved in Response to High Dose of Ciprofloxacin in Escherichia coli

    by Rui Sun, Xianqi Zhao, Qingtai Meng, Ping Huang, Qian Zhao, Xinyi Liu, Wenli Zhang, Fengmin Zhang, Yingmei Fu

    The global emergence of antibiotic resistance, especially in Gram-negative bacteria, is an urgent threat to public health. Inevitably, considering its extensive use and misuse, resistance toward ciprofloxacin has increased in almost all clinically relevant bacteria. This study aimed to investigate the transcriptome changes at a high concentration of ciprofloxacin in Escherichia coli . In brief, 1,418 differentially expressed genes (DEGs) were identified, from which 773 genes were upregulated by ciprofloxacin, whereas 651 genes were downregulated. Enriched biological pathways reflected the upregulation of biological processes such as DNA damage and repair system, toxin/antitoxin systems, formaldehyde detoxification system. With kyoto encyclopedia of genes and genomes pathway analysis, higher expressed DEGs were associated with “LPS biosynthesis,” “streptomycin biosynthesis,” and “polyketide sugar unit biosynthesis.” Lower expressed DEGs were associated with “biosynthesis of amino acids” and “flagellar assembly” pathways. After treatment of ciprofloxacin, lipopolysaccharide (LPS) release was increased by two times, and the gene expression level of LPS synthesis was elevated ( p < 0.05) in both reference and clinical strains. Our results demonstrated that transient exposure to high-dose ciprofloxacin is a double-edged sword. Cautions should be taken when administering high-dose antibiotic treatment for infectious diseases.


  • Open Access

    Further evidence and meta-analysis support association of a single nucleotide polymorphism rs4765905 in CACNA1C with schizophrenia

    by Zuxing Wang, Yingmei Fu, Fugui Jiang, Lili Chen, Wenzhong Chen, Xiaoyun Guo, Xingguang Luo


  • Screening of 20 Mycobacterium tuberculosis sRNAs in plasma for detection of active pulmonary tuberculosis

    by Xue Han, Ting Li, Yunfan Fan, Xinyang Wang, Wei Gu, Weinan Lu, Yian Yin, Qingtai Meng, Wenli Zhang, Jizi Zhao, et al.


  • Open Access

    Genome-wide screening and characterization of genes involved in response to high dose of ciprofloxacin in Escherichia coli

    by Rui Sun, Chunmei Zhang, Xianqi Zhao, Xue Han, Qian Zhao, Peidong Jiang, Xinyi Liu, Wenli Zhang, Fengmin Zhang, Yingmei Fu

    Background Antibiotic resistance is an urgent threat to public health. Prior to the evolution of antibiotic resistance, bacteria frequently undergo response and tend to develop a state of adaption to the antibiotic. Ciprofloxacin is a broad-spectrum antibiotic by damaging DNA. With the widespread clinical application, the resistance of bacteria to ciprofloxacin continues to increase. This study aimed to investigate the transcriptome changes under the action of high concentration of ciprofloxacin in Escherichia coli. Results We identified 773 higher expressed differentially expressed genes (DEGs) and 645 lower expressed DEGs in ciprofloxacin treated cells. Enriched biological pathways reflected the up-regulation of biological process such as DNA damage and repair system, toxin/antitoxin systems, formaldehyde detoxification system, peptide biosynthetic process and cellular protein metabolic process. With KEGG pathway analysis, higher expressed DEGs of kdsA and waa operon were associated with “LPS biosynthesis”. rfbABC operon was related to “streptomycin biosynthesis” and “polyketide sugar unit biosynthesis ”. Lower expressed DEGs of thrABC and fliL operons were associated with “flagellum-dependent cell motility” and “bacterial-type flagellum” in GO terms, and enriched into “biosynthesis of amino acids” and “flagellar assembly” in KEGG pathways. After treatment of ciprofloxacin, bacterial lipopolysacchride (LPS) release was increased by two times, and the mRNA expression level of LPS synthesis genes, waaB, waaP and waaG were elevated (P < 0.05). Conclusions Characterization of the gene clusters by RNA-seq showed high dose of ciprofloxacin not only lead to damage of bacterial macromolecules and components, but also induce protective response against antibiotic action by up-regulating the SOS system, toxin/antitoxin system and formaldehyde detoxification system. Moreover, genes related to biosynthesis of LPS were also higher expressed by the treatment indicating that ciprofloxacin can enhance the production of endotoxin on the level of transcription. These results demonstrated that transient exposure of high dose ciprofloxacin is double edged. Cautions should be taken when administering the high dose antibiotic treatment for infectious diseases.